Request Deal Involvement
Fulgent Genetics to acquire selected assets of Bako Diagnostics, and StrataDx from Consonance Capital for $55m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Mintz Levin
pr advisors
Blueshirt Group
financial advisors
Piper Sandler
legal advisors
Latham & Watkins
financial advisors
EV Health Partners
financial advisors
EV Health Partners
legal advisors
Latham & Watkins
financial advisors
EV Health Partners
legal advisors
Latham & Watkins
or
Principals
bidder
FULGENT GENETICS
vendor
BAKOTIC PATHOLOGY ASSOCIATES LLC
target
BAKOTIC PATHOLOGY ASSOCIATES LLC (SELECTED ASSETS)
vendor
CONSONANCE CAPITAL PARTNERS LLC
target
STRATADX
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite